Triomics growth playbook

Replace every placeholder with a real one-line description of each product, write a title and description for each page that says what it does and for whom ("AI trial matching for cancer centers | PRISM by Triomics"), add one H1 per page, and check what an AI assistant now says when asked "What does Triomics do?".

It is an afternoon of Webflow work, and in a market where buyers at MSK, MD Anderson and pharma sponsors judge rigor, placeholder text is the most expensive thing on the site.

[ ] No "lorem ipsum" or dummy text in the HTML (menus and hidden tabs included)
[ ] Page title names the product, the job and the buyer
[ ] Meta description written (under 160 characters)
[ ] One H1 on the page
[ ] Every number has a source line
[ ] The page is in the XML sitemap

• Placeholders return when the menu is edited

  Add a pre-publish check for "lorem" to the Webflow process.

• Your websiteHomepage HTML: the menu cards for Cancer Centers, Harmony, Life Sciences, Prism and About read "Go from unstructured EHR to structured lorem ipsum", with "lorem ipsum dolor sit amet" in the "Latest" panel; the page title is just "Triomics", there is no meta description and no H1. Stats shown: 120,000+ charts read monthly, 65,000+ patients screened for trials monthly, 70% faster chart review, 10+ NCI-designated customers, a 30% lift in trial accruals and 95% published accuracy (ASCO 2025 abstract).Source
• Your websitetriomics.com/sitemap.xml returns a "Not Found" page, so search engines and AI assistants get no list of the product, resource and press pages; section pages (Life Sciences, Cancer Centers, Prism, About, Resources) have titles like "Triomics | Life sciences overview" and no meta descriptions.Source
• HiringGTM, Biopharma (posted July 22, 2026, New York): "our first commercial hire focused on biopharma", a build role to map the market, define how Triomics sells into life sciences and "stand up a commercial motion that doesn't exist yet, distinct from our cancer center site deals"; translate the product into clinical development, real-world data and trial operations language for clinical, data, operations and procurement buyers; land a first use case and grow it; variable pay tied to closing. "Biopharma is a major part of where we grow next, and right now it's a blank sheet."Source

Rebuild the page around what a sponsor's clinical operations lead needs: the site footprint (named centers that agree), patients screened monthly, an anonymized example of a feasibility count turned around in hours, and an example of a criterion that excluded most patients. Add a two-page PDF for the first outreach.

Sponsors buy from vendors who already sit inside their sites. Showing the footprint and one worked example turns a capability list into a reason to take a call.

• Centers will not be named for sponsors

  Use counts (NCI-designated centers, community practices) and the public names from the press release.

• Your websiteLife Sciences page: "AI deployed where your trials enroll", built on 4 of the top 10 U.S. cancer centers and 10+ NCI-designated centers; four sponsor capabilities (accelerated enrollment, screening throughput visibility by protocol, feasibility with fully-eligible patient counts "in hours, not weeks", and trial design insight into which criteria exclude patients). Its "Working with leading oncology sponsors" section names no sponsor.Source
• HiringGTM, Biopharma (posted July 22, 2026, New York): "our first commercial hire focused on biopharma", a build role to map the market, define how Triomics sells into life sciences and "stand up a commercial motion that doesn't exist yet, distinct from our cancer center site deals"; translate the product into clinical development, real-world data and trial operations language for clinical, data, operations and procurement buyers; land a first use case and grow it; variable pay tied to closing. "Biopharma is a major part of where we grow next, and right now it's a blank sheet."Source
• Your websiteMay 27, 2026 release: a $22 million Series B led by Battery Ventures with Nexus, Lightspeed and Y Combinator, plus Oncology Ventures and Precision Health Informatics (a subsidiary of Texas Oncology); more than $36 million raised in total; funds go to adoption across health systems, oncology networks and life sciences. Customers named: Memorial Sloan Kettering, MD Anderson, Yale Cancer Center and Smilow Cancer Hospital, Mount Sinai Tisch Cancer Center and Texas Oncology. Founded in 2021 by Sarim Khan (CEO) and Hrituraj Singh (CTO).Source
• Your websiteHomepage HTML: the menu cards for Cancer Centers, Harmony, Life Sciences, Prism and About read "Go from unstructured EHR to structured lorem ipsum", with "lorem ipsum dolor sit amet" in the "Latest" panel; the page title is just "Triomics", there is no meta description and no H1. Stats shown: 120,000+ charts read monthly, 65,000+ patients screened for trials monthly, 70% faster chart review, 10+ NCI-designated customers, a 30% lift in trial accruals and 95% published accuracy (ASCO 2025 abstract).Source

Turn on Webflow's sitemap, submit it in Search Console, add descriptions to the resource posts, and use one investor sentence (from the Series B release) in every job post, the About page and decks.

Small hygiene that makes everything else findable and keeps diligence-minded buyers from spotting contradictions.

• None

  Low risk.

• Your websitetriomics.com/sitemap.xml returns a "Not Found" page, so search engines and AI assistants get no list of the product, resource and press pages; section pages (Life Sciences, Cancer Centers, Prism, About, Resources) have titles like "Triomics | Life sciences overview" and no meta descriptions.Source
• HiringJob posts describe Triomics as "the agentic AI layer for oncology EHRs", "trusted by 4 of the top 10 Best Hospitals for Cancer by U.S. News" and "several of the largest community practices", grown 10x in the last year and processing millions of oncology documents a month. The investor lists differ between posts: one names Lightspeed, General Catalyst, Nexus and Y Combinator; another adds Battery Ventures.Source
• Your websiteMay 27, 2026 release: a $22 million Series B led by Battery Ventures with Nexus, Lightspeed and Y Combinator, plus Oncology Ventures and Precision Health Informatics (a subsidiary of Texas Oncology); more than $36 million raised in total; funds go to adoption across health systems, oncology networks and life sciences. Customers named: Memorial Sloan Kettering, MD Anderson, Yale Cancer Center and Smilow Cancer Hospital, Mount Sinai Tisch Cancer Center and Texas Oncology. Founded in 2021 by Sarim Khan (CEO) and Hrituraj Singh (CTO).Source

Two calendars: provider events (ASCO meetings, community oncology and cancer center administrator meetings, registry meetings for Harmony) and sponsor events (clinical operations and site conferences). For each, book meetings beforehand with targets, host one small dinner, and set a follow-up rule.

With a small team, a dinner for ten research directors or sponsor operations leads can produce more pipeline than a booth.

• Too many events

  Cap at what produced meetings last quarter.

• HiringEvent Marketing Manager (posted July 22, 2026): own conferences, activations and Triomics-hosted dinners and field events end to end; generate and qualify leads on site and hand them to sales; build pre-event outreach and post-event follow-up; track which events produce pipeline; travel about twice a quarter, up to monthly. "We recently closed a Series B and getting in front of the right people in person is a big part of how we grow."Source
• HiringGTM, Biopharma (posted July 22, 2026, New York): "our first commercial hire focused on biopharma", a build role to map the market, define how Triomics sells into life sciences and "stand up a commercial motion that doesn't exist yet, distinct from our cancer center site deals"; translate the product into clinical development, real-world data and trial operations language for clinical, data, operations and procurement buyers; land a first use case and grow it; variable pay tied to closing. "Biopharma is a major part of where we grow next, and right now it's a blank sheet."Source
• Your websiteResources: press on MSK deploying Triomics for trial matching (November 2025), a Savista partnership for an automated cancer registry service (November 2025), Connecticut trial screening (November 2025) and Mount Sinai launching PRISM (January 2026); a 2025 ASCO Quality Care Symposium paper reporting a >30% increase in treatment trial accruals; a single anonymous case study from an NCI-designated center.Source

A row of the named centers (with permission, using the public release as the basis), each linked to its press story, plus a line for community practices.

Named academic centers are the strongest proof in oncology; using names already public costs nothing.

• Logo rules

  Use names as text where logos are not allowed.

• Your websiteMay 27, 2026 release: a $22 million Series B led by Battery Ventures with Nexus, Lightspeed and Y Combinator, plus Oncology Ventures and Precision Health Informatics (a subsidiary of Texas Oncology); more than $36 million raised in total; funds go to adoption across health systems, oncology networks and life sciences. Customers named: Memorial Sloan Kettering, MD Anderson, Yale Cancer Center and Smilow Cancer Hospital, Mount Sinai Tisch Cancer Center and Texas Oncology. Founded in 2021 by Sarim Khan (CEO) and Hrituraj Singh (CTO).Source
• Your websiteHomepage HTML: the menu cards for Cancer Centers, Harmony, Life Sciences, Prism and About read "Go from unstructured EHR to structured lorem ipsum", with "lorem ipsum dolor sit amet" in the "Latest" panel; the page title is just "Triomics", there is no meta description and no H1. Stats shown: 120,000+ charts read monthly, 65,000+ patients screened for trials monthly, 70% faster chart review, 10+ NCI-designated customers, a 30% lift in trial accruals and 95% published accuracy (ASCO 2025 abstract).Source
• Your websiteResources: press on MSK deploying Triomics for trial matching (November 2025), a Savista partnership for an automated cancer registry service (November 2025), Connecticut trial screening (November 2025) and Mount Sinai launching PRISM (January 2026); a 2025 ASCO Quality Care Symposium paper reporting a >30% increase in treatment trial accruals; a single anonymous case study from an NCI-designated center.Source

A one-page brief: the setting, the method, the accrual lift, accuracy, coordinator time saved, and what it would mean at the reader's center. The Clinical Navigator and Account Manager use it in every new account and the Event Manager hands it out.

Research directors trust peer-reviewed numbers, and a brief that translates them to their center starts the right conversation.

• Over-generalizing one center's result

  State the setting clearly.

• Your websiteResources: press on MSK deploying Triomics for trial matching (November 2025), a Savista partnership for an automated cancer registry service (November 2025), Connecticut trial screening (November 2025) and Mount Sinai launching PRISM (January 2026); a 2025 ASCO Quality Care Symposium paper reporting a >30% increase in treatment trial accruals; a single anonymous case study from an NCI-designated center.Source
• Your websiteHomepage HTML: the menu cards for Cancer Centers, Harmony, Life Sciences, Prism and About read "Go from unstructured EHR to structured lorem ipsum", with "lorem ipsum dolor sit amet" in the "Latest" panel; the page title is just "Triomics", there is no meta description and no H1. Stats shown: 120,000+ charts read monthly, 65,000+ patients screened for trials monthly, 70% faster chart review, 10+ NCI-designated customers, a 30% lift in trial accruals and 95% published accuracy (ASCO 2025 abstract).Source
• HiringOncology Clinical Navigator (train physicians, nurses and clinical research coordinators, build adoption plans and find champions at each cancer center), an Implementation Project Manager, and a Technical Support Engineer who supports research coordinators, tumor registrars and data managers and watches ingestion failures and extraction accuracy. ML, platform and SRE roles are open in India.Source

For a target sponsor, run one oncology protocol's criteria against participating sites (with the sites' agreement and only aggregate counts shared), and return eligible counts by site and the criteria that excluded most patients, within a week.

Feasibility is a painful, slow step for sponsors; a fast, real answer is the best first use case to land and expand.

• Sites decline

  Start with sites that are strategic partners.

• Privacy concerns

  Aggregate counts only, small numbers suppressed.

• Your websiteLife Sciences page: "AI deployed where your trials enroll", built on 4 of the top 10 U.S. cancer centers and 10+ NCI-designated centers; four sponsor capabilities (accelerated enrollment, screening throughput visibility by protocol, feasibility with fully-eligible patient counts "in hours, not weeks", and trial design insight into which criteria exclude patients). Its "Working with leading oncology sponsors" section names no sponsor.Source
• HiringGTM, Biopharma (posted July 22, 2026, New York): "our first commercial hire focused on biopharma", a build role to map the market, define how Triomics sells into life sciences and "stand up a commercial motion that doesn't exist yet, distinct from our cancer center site deals"; translate the product into clinical development, real-world data and trial operations language for clinical, data, operations and procurement buyers; land a first use case and grow it; variable pay tied to closing. "Biopharma is a major part of where we grow next, and right now it's a blank sheet."Source
• Your websiteCancer Centers page: OncoLLM, "a constellation of eight specialized models, ranging from 3B to 72B parameters"; OncoIndexer ingests HL7, FHIR, CCDA, PDF and TIFF; native integrations with Epic, OncoEMR and iKnowMed, "Approved on the Epic App Marketplace"; 1,800,000+ medical records processed. Products: PRISM (trial matching), Symphony (visit preparation) and Harmony (cancer registry and quality reporting).Source

A small community for CRCs and research nurses using PRISM: a monthly call, shared tips, recognition, early features. Champions present at events and refer peers.

Coordinators are the daily users and the best advocates; their word reaches other centers before sales does.

• Time-poor coordinators

  Keep it monthly and short.

• HiringOncology Clinical Navigator (train physicians, nurses and clinical research coordinators, build adoption plans and find champions at each cancer center), an Implementation Project Manager, and a Technical Support Engineer who supports research coordinators, tumor registrars and data managers and watches ingestion failures and extraction accuracy. ML, platform and SRE roles are open in India.Source
• HiringAccount Manager (posted June 17, 2026): "a customer success and account ownership role, not a quota-carrying upsell seat", owning each account from closed-won through integration, go-live and steady state; coordinating Forward Deployed Engineers and Clinical Navigators; building adoption reporting and KPIs; and building the playbooks that let delivery scale "from a handful to 25+ enterprise logos", with handoffs, expansion readiness and renewals coordinated with Commercial.Source
• HiringEvent Marketing Manager (posted July 22, 2026): own conferences, activations and Triomics-hosted dinners and field events end to end; generate and qualify leads on site and hand them to sales; build pre-event outreach and post-event follow-up; track which events produce pipeline; travel about twice a quarter, up to monthly. "We recently closed a Series B and getting in front of the right people in person is a big part of how we grow."Source

A standard quarterly outcomes report per account: patients screened, matches, enrollments where available, coordinator hours saved, accuracy checks. Each report doubles as raw material for a case study.

It makes value visible to the people who renew and creates the proof sales needs to go from a handful to 25+ logos.

• Enrollment data hard to get

  Report screening and matches where enrollment is not tracked.

• HiringAccount Manager (posted June 17, 2026): "a customer success and account ownership role, not a quota-carrying upsell seat", owning each account from closed-won through integration, go-live and steady state; coordinating Forward Deployed Engineers and Clinical Navigators; building adoption reporting and KPIs; and building the playbooks that let delivery scale "from a handful to 25+ enterprise logos", with handoffs, expansion readiness and renewals coordinated with Commercial.Source
• Your websiteHomepage HTML: the menu cards for Cancer Centers, Harmony, Life Sciences, Prism and About read "Go from unstructured EHR to structured lorem ipsum", with "lorem ipsum dolor sit amet" in the "Latest" panel; the page title is just "Triomics", there is no meta description and no H1. Stats shown: 120,000+ charts read monthly, 65,000+ patients screened for trials monthly, 70% faster chart review, 10+ NCI-designated customers, a 30% lift in trial accruals and 95% published accuracy (ASCO 2025 abstract).Source
• HiringOncology Clinical Navigator (train physicians, nurses and clinical research coordinators, build adoption plans and find champions at each cancer center), an Implementation Project Manager, and a Technical Support Engineer who supports research coordinators, tumor registrars and data managers and watches ingestion failures and extraction accuracy. ML, platform and SRE roles are open in India.Source

Make the listing complete (use cases, outcomes, named customers), present with a customer at Epic-focused community events, and publish an integration guide for informatics teams.

Informatics leaders can block or speed a deal; meeting them where they evaluate apps shortens security and integration review.

• Marketplace rules

  Follow listing terms.

• Your websiteCancer Centers page: OncoLLM, "a constellation of eight specialized models, ranging from 3B to 72B parameters"; OncoIndexer ingests HL7, FHIR, CCDA, PDF and TIFF; native integrations with Epic, OncoEMR and iKnowMed, "Approved on the Epic App Marketplace"; 1,800,000+ medical records processed. Products: PRISM (trial matching), Symphony (visit preparation) and Harmony (cancer registry and quality reporting).Source
• Your websiteMay 27, 2026 release: a $22 million Series B led by Battery Ventures with Nexus, Lightspeed and Y Combinator, plus Oncology Ventures and Precision Health Informatics (a subsidiary of Texas Oncology); more than $36 million raised in total; funds go to adoption across health systems, oncology networks and life sciences. Customers named: Memorial Sloan Kettering, MD Anderson, Yale Cancer Center and Smilow Cancer Hospital, Mount Sinai Tisch Cancer Center and Texas Oncology. Founded in 2021 by Sarim Khan (CEO) and Hrituraj Singh (CTO).Source

A joint go-to-market with Savista: a webinar for registry leaders, a joint case, and presence at registry meetings, with Harmony as the entry product that later opens PRISM.

A partner already sells to registry teams, and registry work is a quicker yes than trial matching at some centers.

• Partner priorities differ

  Agree shared targets.

• Your websiteResources: press on MSK deploying Triomics for trial matching (November 2025), a Savista partnership for an automated cancer registry service (November 2025), Connecticut trial screening (November 2025) and Mount Sinai launching PRISM (January 2026); a 2025 ASCO Quality Care Symposium paper reporting a >30% increase in treatment trial accruals; a single anonymous case study from an NCI-designated center.Source
• Your websiteHomepage HTML: the menu cards for Cancer Centers, Harmony, Life Sciences, Prism and About read "Go from unstructured EHR to structured lorem ipsum", with "lorem ipsum dolor sit amet" in the "Latest" panel; the page title is just "Triomics", there is no meta description and no H1. Stats shown: 120,000+ charts read monthly, 65,000+ patients screened for trials monthly, 70% faster chart review, 10+ NCI-designated customers, a 30% lift in trial accruals and 95% published accuracy (ASCO 2025 abstract).Source
• Your websiteCancer Centers page: OncoLLM, "a constellation of eight specialized models, ranging from 3B to 72B parameters"; OncoIndexer ingests HL7, FHIR, CCDA, PDF and TIFF; native integrations with Epic, OncoEMR and iKnowMed, "Approved on the Epic App Marketplace"; 1,800,000+ medical records processed. Products: PRISM (trial matching), Symphony (visit preparation) and Harmony (cancer registry and quality reporting).Source

A community oncology offer built from the Texas Oncology deployment: Symphony visit preparation as the entry (the 80% and 45% reductions in pre-charting time), PRISM for research sites, and a network-wide price. Ask Texas Oncology for a reference call program.

One network deal covers many sites, and a peer network that also invested is the strongest reference.

• Investor reference seen as biased

  Pair it with another community practice.

• Your websiteMay 27, 2026 release: a $22 million Series B led by Battery Ventures with Nexus, Lightspeed and Y Combinator, plus Oncology Ventures and Precision Health Informatics (a subsidiary of Texas Oncology); more than $36 million raised in total; funds go to adoption across health systems, oncology networks and life sciences. Customers named: Memorial Sloan Kettering, MD Anderson, Yale Cancer Center and Smilow Cancer Hospital, Mount Sinai Tisch Cancer Center and Texas Oncology. Founded in 2021 by Sarim Khan (CEO) and Hrituraj Singh (CTO).Source
• Your websiteHomepage HTML: the menu cards for Cancer Centers, Harmony, Life Sciences, Prism and About read "Go from unstructured EHR to structured lorem ipsum", with "lorem ipsum dolor sit amet" in the "Latest" panel; the page title is just "Triomics", there is no meta description and no H1. Stats shown: 120,000+ charts read monthly, 65,000+ patients screened for trials monthly, 70% faster chart review, 10+ NCI-designated customers, a 30% lift in trial accruals and 95% published accuracy (ASCO 2025 abstract).Source
• HiringGTM, Biopharma (posted July 22, 2026, New York): "our first commercial hire focused on biopharma", a build role to map the market, define how Triomics sells into life sciences and "stand up a commercial motion that doesn't exist yet, distinct from our cancer center site deals"; translate the product into clinical development, real-world data and trial operations language for clinical, data, operations and procurement buyers; land a first use case and grow it; variable pay tied to closing. "Biopharma is a major part of where we grow next, and right now it's a blank sheet."Source

Plan one abstract or paper per major customer per year (accrual lift, pre-charting time, registry accuracy), timed to ASCO and other oncology meetings, with Triomics handling analysis and drafting.

Academic centers buy what their peers publish; publications also give the event team talks to give.

• IRB delays

  Start with quality improvement studies.

• Your websiteResources: press on MSK deploying Triomics for trial matching (November 2025), a Savista partnership for an automated cancer registry service (November 2025), Connecticut trial screening (November 2025) and Mount Sinai launching PRISM (January 2026); a 2025 ASCO Quality Care Symposium paper reporting a >30% increase in treatment trial accruals; a single anonymous case study from an NCI-designated center.Source
• Your websiteHomepage HTML: the menu cards for Cancer Centers, Harmony, Life Sciences, Prism and About read "Go from unstructured EHR to structured lorem ipsum", with "lorem ipsum dolor sit amet" in the "Latest" panel; the page title is just "Triomics", there is no meta description and no H1. Stats shown: 120,000+ charts read monthly, 65,000+ patients screened for trials monthly, 70% faster chart review, 10+ NCI-designated customers, a 30% lift in trial accruals and 95% published accuracy (ASCO 2025 abstract).Source
• HiringEvent Marketing Manager (posted July 22, 2026): own conferences, activations and Triomics-hosted dinners and field events end to end; generate and qualify leads on site and hand them to sales; build pre-event outreach and post-event follow-up; track which events produce pipeline; travel about twice a quarter, up to monthly. "We recently closed a Series B and getting in front of the right people in person is a big part of how we grow."Source

A short public page on how Triomics monitors accuracy and data quality in production, support response targets, and how errors are fixed, plus the security header fixes (graded F) before security reviews flag them.

Clinical and IT reviewers need this to approve, and showing it openly is rare in AI vendors.

• Disclosing too much

  Describe process, not internals.

• HiringOncology Clinical Navigator (train physicians, nurses and clinical research coordinators, build adoption plans and find champions at each cancer center), an Implementation Project Manager, and a Technical Support Engineer who supports research coordinators, tumor registrars and data managers and watches ingestion failures and extraction accuracy. ML, platform and SRE roles are open in India.Source
• programmable.infoSite scan: Chrome UX Report LCP 1.0 s (fast); security headers graded F (18/100); Webflow on Cloudflare; LinkedIn and X accounts, no YouTube; a help center at help.triomics.com and a partnerships@ address on the homepage.Source
• Your websiteCancer Centers page: OncoLLM, "a constellation of eight specialized models, ranging from 3B to 72B parameters"; OncoIndexer ingests HL7, FHIR, CCDA, PDF and TIFF; native integrations with Epic, OncoEMR and iKnowMed, "Approved on the Epic App Marketplace"; 1,800,000+ medical records processed. Products: PRISM (trial matching), Symphony (visit preparation) and Harmony (cancer registry and quality reporting).Source

An annual sponsor subscription: per-protocol dashboards of pre-screening, eligibility and exclusions across participating sites, with a share of revenue going to the sites that opt in, so sites gain from joining.

It turns the cancer center footprint into a second, recurring business with sponsors and gives sites a reason to adopt and stay.

• Sites wary of sponsor visibility

  Aggregate only, site approval, clear benefit.

• Your websiteLife Sciences page: "AI deployed where your trials enroll", built on 4 of the top 10 U.S. cancer centers and 10+ NCI-designated centers; four sponsor capabilities (accelerated enrollment, screening throughput visibility by protocol, feasibility with fully-eligible patient counts "in hours, not weeks", and trial design insight into which criteria exclude patients). Its "Working with leading oncology sponsors" section names no sponsor.Source
• HiringGTM, Biopharma (posted July 22, 2026, New York): "our first commercial hire focused on biopharma", a build role to map the market, define how Triomics sells into life sciences and "stand up a commercial motion that doesn't exist yet, distinct from our cancer center site deals"; translate the product into clinical development, real-world data and trial operations language for clinical, data, operations and procurement buyers; land a first use case and grow it; variable pay tied to closing. "Biopharma is a major part of where we grow next, and right now it's a blank sheet."Source
• Your websiteMay 27, 2026 release: a $22 million Series B led by Battery Ventures with Nexus, Lightspeed and Y Combinator, plus Oncology Ventures and Precision Health Informatics (a subsidiary of Texas Oncology); more than $36 million raised in total; funds go to adoption across health systems, oncology networks and life sciences. Customers named: Memorial Sloan Kettering, MD Anderson, Yale Cancer Center and Smilow Cancer Hospital, Mount Sinai Tisch Cancer Center and Texas Oncology. Founded in 2021 by Sarim Khan (CEO) and Hrituraj Singh (CTO).Source

Offer sponsors a package that pays to deploy PRISM at community sites where their trials enroll, with the site keeping the tool after the trial. Triomics gains sites; sponsors gain enrollment and diverse patients.

It grows the site footprint without waiting for hospital budgets, which in turn makes the sponsor products stronger.

• Regulatory and inducement concerns

  Legal design up front; fair-market terms.

• Your websiteResources: press on MSK deploying Triomics for trial matching (November 2025), a Savista partnership for an automated cancer registry service (November 2025), Connecticut trial screening (November 2025) and Mount Sinai launching PRISM (January 2026); a 2025 ASCO Quality Care Symposium paper reporting a >30% increase in treatment trial accruals; a single anonymous case study from an NCI-designated center.Source
• Your websiteLife Sciences page: "AI deployed where your trials enroll", built on 4 of the top 10 U.S. cancer centers and 10+ NCI-designated centers; four sponsor capabilities (accelerated enrollment, screening throughput visibility by protocol, feasibility with fully-eligible patient counts "in hours, not weeks", and trial design insight into which criteria exclude patients). Its "Working with leading oncology sponsors" section names no sponsor.Source
• Your websiteMay 27, 2026 release: a $22 million Series B led by Battery Ventures with Nexus, Lightspeed and Y Combinator, plus Oncology Ventures and Precision Health Informatics (a subsidiary of Texas Oncology); more than $36 million raised in total; funds go to adoption across health systems, oncology networks and life sciences. Customers named: Memorial Sloan Kettering, MD Anderson, Yale Cancer Center and Smilow Cancer Hospital, Mount Sinai Tisch Cancer Center and Texas Oncology. Founded in 2021 by Sarim Khan (CEO) and Hrituraj Singh (CTO).Source

Pick the next one or two EHRs by the number of target sites, build native integrations through OncoIndexer, and launch with a lighthouse customer on each.

Each integration opens a block of sites the sales team cannot sell today.

• Integration effort

  Use FHIR where possible.

• Your websiteCancer Centers page: OncoLLM, "a constellation of eight specialized models, ranging from 3B to 72B parameters"; OncoIndexer ingests HL7, FHIR, CCDA, PDF and TIFF; native integrations with Epic, OncoEMR and iKnowMed, "Approved on the Epic App Marketplace"; 1,800,000+ medical records processed. Products: PRISM (trial matching), Symphony (visit preparation) and Harmony (cancer registry and quality reporting).Source
• Your websiteMay 27, 2026 release: a $22 million Series B led by Battery Ventures with Nexus, Lightspeed and Y Combinator, plus Oncology Ventures and Precision Health Informatics (a subsidiary of Texas Oncology); more than $36 million raised in total; funds go to adoption across health systems, oncology networks and life sciences. Customers named: Memorial Sloan Kettering, MD Anderson, Yale Cancer Center and Smilow Cancer Hospital, Mount Sinai Tisch Cancer Center and Texas Oncology. Founded in 2021 by Sarim Khan (CEO) and Hrituraj Singh (CTO).Source

A one-day invite-only summit for research, registry and operations leaders, with customer talks and no product pitches, plus a sponsor track.

Owning the conversation in a niche brings buyers to Triomics instead of competing for booth traffic.

• Low attendance

  Start as a dinner series.

• HiringEvent Marketing Manager (posted July 22, 2026): own conferences, activations and Triomics-hosted dinners and field events end to end; generate and qualify leads on site and hand them to sales; build pre-event outreach and post-event follow-up; track which events produce pipeline; travel about twice a quarter, up to monthly. "We recently closed a Series B and getting in front of the right people in person is a big part of how we grow."Source
• Your websiteMay 27, 2026 release: a $22 million Series B led by Battery Ventures with Nexus, Lightspeed and Y Combinator, plus Oncology Ventures and Precision Health Informatics (a subsidiary of Texas Oncology); more than $36 million raised in total; funds go to adoption across health systems, oncology networks and life sciences. Customers named: Memorial Sloan Kettering, MD Anderson, Yale Cancer Center and Smilow Cancer Hospital, Mount Sinai Tisch Cancer Center and Texas Oncology. Founded in 2021 by Sarim Khan (CEO) and Hrituraj Singh (CTO).Source
• Your websiteResources: press on MSK deploying Triomics for trial matching (November 2025), a Savista partnership for an automated cancer registry service (November 2025), Connecticut trial screening (November 2025) and Mount Sinai launching PRISM (January 2026); a 2025 ASCO Quality Care Symposium paper reporting a >30% increase in treatment trial accruals; a single anonymous case study from an NCI-designated center.Source

A public, versioned scorecard of accuracy by task and cancer type, with the method, updated each release.

It makes Triomics the vendor that shows its work, which matches its "every output is cited" promise and pressures rivals.

• Numbers drop

  Show trends and fixes honestly.

• Your websiteHomepage HTML: the menu cards for Cancer Centers, Harmony, Life Sciences, Prism and About read "Go from unstructured EHR to structured lorem ipsum", with "lorem ipsum dolor sit amet" in the "Latest" panel; the page title is just "Triomics", there is no meta description and no H1. Stats shown: 120,000+ charts read monthly, 65,000+ patients screened for trials monthly, 70% faster chart review, 10+ NCI-designated customers, a 30% lift in trial accruals and 95% published accuracy (ASCO 2025 abstract).Source
• Your websiteCancer Centers page: OncoLLM, "a constellation of eight specialized models, ranging from 3B to 72B parameters"; OncoIndexer ingests HL7, FHIR, CCDA, PDF and TIFF; native integrations with Epic, OncoEMR and iKnowMed, "Approved on the Epic App Marketplace"; 1,800,000+ medical records processed. Products: PRISM (trial matching), Symphony (visit preparation) and Harmony (cancer registry and quality reporting).Source
• Competitor researchA 2026 market guide groups Tempus (which acquired Deep 6 AI in March 2025), ConcertAI and Mendel as EHR-based trial matching engines, and Triomics and Massive Bio as oncology copilots for cancer center coordinators; Tempus and IQVIA expanded oncology trial matching for sponsors in 2026.See the research Source

A calculator for administrators: current accruals, trials, per-patient research revenue they enter, and what a 30% lift would mean, alongside coordinator time saved.

It speaks to the budget holder who signs, not only the research team.

• Revenue varies widely

  Users enter their own numbers.

• Your websiteHomepage HTML: the menu cards for Cancer Centers, Harmony, Life Sciences, Prism and About read "Go from unstructured EHR to structured lorem ipsum", with "lorem ipsum dolor sit amet" in the "Latest" panel; the page title is just "Triomics", there is no meta description and no H1. Stats shown: 120,000+ charts read monthly, 65,000+ patients screened for trials monthly, 70% faster chart review, 10+ NCI-designated customers, a 30% lift in trial accruals and 95% published accuracy (ASCO 2025 abstract).Source
• Your websiteResources: press on MSK deploying Triomics for trial matching (November 2025), a Savista partnership for an automated cancer registry service (November 2025), Connecticut trial screening (November 2025) and Mount Sinai launching PRISM (January 2026); a 2025 ASCO Quality Care Symposium paper reporting a >30% increase in treatment trial accruals; a single anonymous case study from an NCI-designated center.Source

A short free online course (with a certificate) on pre-screening with AI: what to trust, how to check citations, how to work a worklist, taught by Clinical Navigators.

It builds a following among the people who recommend tools, at every center, before Triomics sells there.

• Seen as marketing

  Keep it vendor-neutral and useful.

• HiringOncology Clinical Navigator (train physicians, nurses and clinical research coordinators, build adoption plans and find champions at each cancer center), an Implementation Project Manager, and a Technical Support Engineer who supports research coordinators, tumor registrars and data managers and watches ingestion failures and extraction accuracy. ML, platform and SRE roles are open in India.Source
• Your websiteCancer Centers page: OncoLLM, "a constellation of eight specialized models, ranging from 3B to 72B parameters"; OncoIndexer ingests HL7, FHIR, CCDA, PDF and TIFF; native integrations with Epic, OncoEMR and iKnowMed, "Approved on the Epic App Marketplace"; 1,800,000+ medical records processed. Products: PRISM (trial matching), Symphony (visit preparation) and Harmony (cancer registry and quality reporting).Source